Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.

Sci Rep

Department of Laboratory Medicine and Pathology, Cross Cancer Institute, University of Alberta, AB, Canada.

Published: May 2014

Mitotic count, PhH3, and MIB-1 are used as measures of the proportion of proliferating malignant cells in surgical pathology. They highlight different stages of the cell cycle, but little is known about how this affects their counts. This study assesses the strength of their correlations and attempts to determine the relationship between them. Proliferation counts for forty-nine consecutive cases of invasive breast carcinomas were analyzed, with the same tumor area on each stain counted using digital image analysis. The integrated optical density (IOD) of nuclei was measured as an approximation of nuclear DNA content. PhH3 strongly correlated with mitotic count (r = 0.94). Weaker correlations were found between MIB-1 versus PhH3 (r = 0.79) and mitotic count (r = 0.83). Nuclear IOD showed stronger correlation with MIB-1 (r = 0.37) than to mitotic count (r = 0.23) and PhH3 (r = 0.34). With evidence from a literature review, it is suggested that the weaker correlations with MIB-1 are not explained by count imprecision or error, but relies on temporal decorrelation between cell cycle phases. Consequences on correlation between these proliferative markers are illustrated by mathematical models.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038821PMC
http://dx.doi.org/10.1038/srep05122DOI Listing

Publication Analysis

Top Keywords

mitotic count
16
cell cycle
12
proliferative markers
8
cycle phases
8
weaker correlations
8
correlations mib-1
8
count
5
current breast
4
breast cancer
4
cancer proliferative
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!